Health News

ecigeratte-oct18.jpgAt a time, when e-cigarettes have been getting a lot of bad press, a new study has found a positive association between the number of people using e-cigarettes and the success rate of giving up smoking. The study led by Dr. Emma Beard, UCL Division of Psychology and Language Sciences, showed that...
Read More

Cannabis delivery company Eaze said it has closed a $20 million investment and also secured the ability to raise up to an additional $20 million to complete its Series D funding, which are intended to help the company's verticalization plans. The $20 million in funding from Series D investors, led...
Read More

Interstitial Cystitis Drug Linked To Retinal Damage: Study

Elmiron, the only FDA-approved oral drug to treat interstitial cystitis, also known as bladder pain syndrome, has been found to be associated with a vision-threatening eye condition, according to a new study.
Read More

No Piggy Tale: Some Brain Functions Restored Even Hours After Death

The conventional wisdom is that if the brain cells of humans and other mammals are deprived of oxygen for 4-5 min, they begin to die, and that the loss of brain functions after death is irreversible. But the findings of a study conducted by Yale University researchers challenge these long-held assumptions.
Read More
bornbaby-sept30.jpgA recent study, done by researchers from the Wellcome Sanger Institute, UCL, the University of Birmingham and their collaborators, found that there is a difference in the gut bacteria of babies delivered vaginally and those born via caesarean.
Read More
Follow RTT

FDA Calendar
Event DateSymbolDrug NameEvent Name
05/26/20REGNDupixent (sBLA)FDA decision on Dupixent as an add-on maintenance treatment for children aged 6 to 11 years with moderate-to-severe atopic dermatitis
05/24/20RHHBYRisdiplam (NDA)FDA decision on risdiplam for spinal muscular atrophy
05/24/20PTCTRisdiplam (NDA)FDA decision on Risdiplam for the treatment of spinal muscular atrophy
05/14/20BPMCAvapritinib (NDA)FDA decision on Avapritinib for the treatment of adult patients with fourth-line gastrointestinal stromal tumor (GIST)
05/14/20DNPUFDasotraline (NDA)FDA decision on Dasotraline for the treatment of patients with moderate-to-severe binge eating disorder
05/12/20HALODARZALEX (BLA)FDA decision on subcutaneous delivery of DARZALEX for patients with multiple myeloma.
View All